Clinical Usefulness of Coregistered 11C-Methionine Positron Emission Tomography/3-T Magnetic Resonance Imaging at the Follow-Up of Acromegaly
- 1 September 2014
- journal article
- Published by Elsevier in World Neurosurgery
- Vol. 82 (3-4) , 468-473
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Incidental pituitary uptake on whole-body 18F-FDG PET/CT: a multicentre studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- Pituitary Adenomas Can Appear as Hypermetabolic Lesions in 18F‐FDG PET ImagingJournal of Neuroimaging, 2009
- Guidelines for Acromegaly Management: An UpdateThe Journal of Clinical Endocrinology & Metabolism, 2009
- Positron Emission Tomography in Acromegaly and Other Pituitary Adenoma PatientsNeuroendocrinology, 2006
- Partial Surgical Removal of Growth Hormone-Secreting Pituitary Tumors Enhances the Response to Somatostatin Analogs in AcromegalyThe Journal of Clinical Endocrinology & Metabolism, 2006
- Pituitary Adenoma Detected on FDG Positron Emission Tomography in a Patient with Mucosa-Associated Lymphoid Tissue LymphomaClinical Nuclear Medicine, 2003
- Positron Emission Tomography of Pituitary Macroadenomas: Hormone Production and Effects of TherapiesNeurosurgery, 1991
- Rapid Decrease in Amino Acid Metabolism in Prolactin-Secreting Pituitary Adenomas After Bromocriptine TreatmentJournal of Computer Assisted Tomography, 1987
- The normal pituitary examined with positron emission tomography and (methyl-11C)-L-methionine and (methyl-11C)-D-methionineNeuroradiology, 1987
- Amino Acid Distribution and Metabolism in Pituitary Adenomas Using Positron Emission Tomography with D-[11C]Methionine and L-[11C]MethionineJournal of Computer Assisted Tomography, 1987